Author

M. S. Muhammad Sakri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

H. Jaafar· 1 shared T. A. D. A.-A. Tengku Din· 1 shared V. Gopalan· 1 shared W. F. Wan Abdul rahman· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

H. Jaafar

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PathologybioRxivAug 27, 2020

Rapamycin as a potent and selective inhibitor of vascular endothelial growth factor receptor in breast carcinoma

W. F. Wan Abdul rahman, M. S. Muhammad Sakri, T. A. D. A.-A. Tengku Din…·V. Gopalan

This study evaluates rapamycin and platelet factor-4 on rat breast carcinoma, finding rapamycin effectively downregulates Flt-4 while platelet factor-4 shows limited anti-angiogenic effects.

DOI 10.1177/20587384211059673

ratproteomics

𝕏 PostBluesky